MA45611A - Promoteurs spécifiques des trichomes pour la manipulation de cannabinoïdes et d'autres composés dans des trichomes glandulaires - Google Patents

Promoteurs spécifiques des trichomes pour la manipulation de cannabinoïdes et d'autres composés dans des trichomes glandulaires

Info

Publication number
MA45611A
MA45611A MA045611A MA45611A MA45611A MA 45611 A MA45611 A MA 45611A MA 045611 A MA045611 A MA 045611A MA 45611 A MA45611 A MA 45611A MA 45611 A MA45611 A MA 45611A
Authority
MA
Morocco
Prior art keywords
trichoma
cannabinoids
glandular
promoters
handling
Prior art date
Application number
MA045611A
Other languages
English (en)
Inventor
Paul Rushton
Original Assignee
22Nd Century Ltd Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 22Nd Century Ltd Llc filed Critical 22Nd Century Ltd Llc
Publication of MA45611A publication Critical patent/MA45611A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/8223—Vegetative tissue-specific promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03007—Tetrahydrocannabinolic acid synthase (1.21.3.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03008—Cannabidiolic acid synthase (1.21.3.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/99—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with other acceptors (1.21.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
    • C12Y402/03119—(–)-Alpha-pinene synthase (4.2.3.119)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y404/00—Carbon-sulfur lyases (4.4)
    • C12Y404/01—Carbon-sulfur lyases (4.4.1)
    • C12Y404/01026—Olivetolic acid cyclase (4.4.1.26)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
    • C12Y602/01—Acid-Thiol Ligases (6.2.1)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
MA045611A 2016-09-20 2017-09-14 Promoteurs spécifiques des trichomes pour la manipulation de cannabinoïdes et d'autres composés dans des trichomes glandulaires MA45611A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662397212P 2016-09-20 2016-09-20

Publications (1)

Publication Number Publication Date
MA45611A true MA45611A (fr) 2019-05-15

Family

ID=61691084

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045611A MA45611A (fr) 2016-09-20 2017-09-14 Promoteurs spécifiques des trichomes pour la manipulation de cannabinoïdes et d'autres composés dans des trichomes glandulaires

Country Status (13)

Country Link
US (4) US10787674B2 (fr)
EP (2) EP3516048B1 (fr)
JP (2) JP7220145B2 (fr)
CN (2) CN117587015A (fr)
AU (1) AU2017332638A1 (fr)
CA (1) CA3036968A1 (fr)
EA (1) EA201990549A1 (fr)
ES (1) ES2940673T3 (fr)
MA (1) MA45611A (fr)
MX (2) MX2019003063A (fr)
SG (1) SG10201913280UA (fr)
TW (1) TW201821613A (fr)
WO (1) WO2018057385A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US12617747B2 (en) * 2018-10-31 2026-05-05 Inmed Pharmaceuticals Inc. Cannabinoid analogs and methods for their preparation
US20220154197A1 (en) * 2019-03-12 2022-05-19 Perpetuum Cropscience Bvba Cannabinoid precursor production
CA3145253A1 (fr) * 2019-07-01 2021-01-07 22Nd Century Limited, Llc Promoteurs de terpene synthase du cannabis pour la manipulation de la biosynthese des terpenes dans les trichomes
CA3148950A1 (fr) * 2019-07-30 2021-02-04 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center Methodes de regulation de la synthese de cannabinoides chez la plante ou dans des cellules et plantes et cellules ainsi produites
WO2021067640A1 (fr) * 2019-10-01 2021-04-08 Intima Bioscience, Inc. Plantes génétiquement modifiées et leurs procédés de préparation
CN115066238A (zh) 2019-12-27 2022-09-16 海湾医学公司 大麻色原烯和相关大麻素的制备
US12698516B2 (en) * 2020-11-12 2026-08-04 Technische Universität Darmstadt Production of cannabinoids/phytocannabinoids with a plant extract
EP4288448A1 (fr) 2021-02-03 2023-12-13 Altria Client Services LLC Production de terpène dans des plantes
CN113234726B (zh) * 2021-06-21 2022-07-22 贵州省烟草科学研究院 一种烟草腺毛特异性启动子pNtTCP9a及其应用
CN113528365B (zh) * 2021-07-13 2023-04-07 浙江寿仙谷医药股份有限公司 产大麻二酚的重组酿酒酵母、其构建方法以及应用
US12103950B2 (en) 2022-01-27 2024-10-01 University Of Connecticut Transgenic plants that overexpress a R2R3-MYB transcription factor gene and methods for producing the same
CA3245702A1 (fr) * 2022-03-11 2023-09-14 Yeda Research And Development Co. Ltd. Cellule, tissu ou plante d'helichrysum umbraculigerum transgénique
CN120591301B (zh) * 2025-06-25 2026-04-21 中国农业科学院棉花研究所 一种调节植物种子油脂含量的GhLACS4基因及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
WO2000052168A1 (fr) 1999-02-26 2000-09-08 Cropdesign N.V. Procede de selection de cellules et tissus transformes
JP2003521940A (ja) 2000-02-08 2003-07-22 株式会社サカタのタネ 植物形質転換のための新規方法および構築物
US6730826B2 (en) * 2000-03-22 2004-05-04 University Of Kentucky Research Foundation Plant trichome gland specific promoter sequence
US7534934B2 (en) 2002-02-20 2009-05-19 J.R. Simplot Company Precise breeding
US7498428B2 (en) 2003-06-19 2009-03-03 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
CN103667370B (zh) 2005-07-05 2016-08-10 加利福尼亚大学董事会 编码类异戊烯修饰酶的多核苷酸和其使用方法
EP2554674B1 (fr) * 2007-12-21 2014-11-05 Keygene N.V. Promoteurs spécifiques trichomes
CA3130705A1 (fr) * 2010-04-15 2011-10-20 National Research Council Of Canada Genes et proteines servant a la synthese de polycetides aromatiques
EP2714901B1 (fr) * 2011-05-31 2024-09-18 Keygene N.V. Plantes résistantes aux nuisibles
US9546362B2 (en) 2011-07-13 2017-01-17 National Research Council Of Canada Genes and proteins for alkanoyl-CoA synthesis
US20140057251A1 (en) * 2011-08-18 2014-02-27 Medicinal Genomics Corporation Cannabis Genomes and Uses Thereof
US20160177404A1 (en) * 2011-08-18 2016-06-23 Courtagen Life Sciences Inc. Cannabis genomes and uses thereof
BR112015012270A2 (pt) * 2012-11-30 2017-09-26 Keygene Nv planta, célula de planta, tecido de planta ou orgão transgênica(o), sequência de ácido nucleico isolada, fragmento, gene quimérico, vetor, célula de planta ou planta transgênica, e, método para produzir uma célula de planta ou planta transgênica
US10441617B2 (en) * 2013-03-15 2019-10-15 Biotech Institute, Llc Breeding, production, processing and use of medical cannabis
US10364416B2 (en) * 2014-06-27 2019-07-30 National Research Council Of Canada Cannabichromenic acid synthase from cannabis sativa
BR112017003966A2 (pt) 2014-08-25 2018-10-23 Full Spectrum Laboratories Ltd aparelhos e métodos para a produção simultânea de compostos canabinoides

Also Published As

Publication number Publication date
CN109963941A (zh) 2019-07-02
EP3516048A2 (fr) 2019-07-31
MX2019003063A (es) 2019-10-14
EP4194550A2 (fr) 2023-06-14
JP7220145B2 (ja) 2023-02-09
AU2017332638A1 (en) 2019-04-11
CN109963941B (zh) 2023-12-15
US11649463B2 (en) 2023-05-16
EA201990549A1 (ru) 2019-10-31
JP2019533436A (ja) 2019-11-21
WO2018057385A3 (fr) 2018-05-03
CA3036968A1 (fr) 2018-03-29
JP2022180445A (ja) 2022-12-06
SG10201913280UA (en) 2020-03-30
TW201821613A (zh) 2018-06-16
US20230374531A1 (en) 2023-11-23
CN117587015A (zh) 2024-02-23
US20210040492A1 (en) 2021-02-11
EP3516048B1 (fr) 2023-01-11
ES2940673T3 (es) 2023-05-10
MX2023009165A (es) 2023-08-18
WO2018057385A2 (fr) 2018-03-29
US10787674B2 (en) 2020-09-29
EP4194550A3 (fr) 2023-09-06
US20230383303A1 (en) 2023-11-30
US20190225975A1 (en) 2019-07-25
EP3516048A4 (fr) 2020-07-29

Similar Documents

Publication Publication Date Title
EP3390643A4 (fr) Constructions plasmidiques pour l'expression de protéines hétérologues et leurs procédés d'utilisation
EP3374494A4 (fr) Compositions crispr et leurs méthodes d'utilisation pour la thérapie génique
EP3402549A4 (fr) Compositions pour micro-aiguilles et méthodes d'utilisation de celles-ci
EP3510152A4 (fr) Méthodes et compositions pour moduler l'expression génique
MA71266A (fr) Procédés d'intervention précoce pour prévenir ou améliorer la toxicité
MA71420A (fr) Anticorps anti-cd38 pour le traitement de l'amyloïdose à chaîne légère et d'autres tumeurs malignes hématologiques positives à cd38
SG10201913280UA (en) Trichome specific promoters for the manipulation of cannabinoids and other compounds in glandular trichomes
EP3359164A4 (fr) Composés et procédés pour moduler l'expression de l'angiotensinogène
EP3386550A4 (fr) Procédés et compositions pour la fabrication et l'utilisation d'acides nucléiques de guidage
EP3381438A4 (fr) Composition pour l'injection d'acide hyaluronique, contenant un dérivé de l'acide hyaluronique et une fraction adn, et utilisation de cette dernière
ME03070B (fr) Méthodes pour le traitement d'infections virales à filoviridae
MA46315A (fr) Polythérapies pour malignités hématologiques avec des anticorps anti-cd38 et des inhibiteurs de la survivine
EP3504187A4 (fr) Utilisation de la pridopidine pour le traitement du déclin fonctionnel
EP3302588A4 (fr) Compositions et méthodes pour l'adhérence à des surfaces
EP2971136A4 (fr) Méthodes microfluidiques de manipulation d'adn
EP3394722A4 (fr) Instructions et logique pour des opérations de chargement d'indices et de prélecture de regroupements
EP3328429A4 (fr) Peptides et anticorps pour l'élimination de biofilms
EP2996725A4 (fr) Promoteurs, cassettes d'expression, vecteurs, kits, et méthodes pour le traitement de l'achromatopsie et d'autres maladies
MA46791A (fr) Composés et procédés pour réduire l'expression d'atxn3
EP3381473A4 (fr) Composition pharmaceutique utilisée pour réduire la graisse localisée et utilisation de la composition pharmaceutique
EP3481819A4 (fr) Composés et utilisation de ces derniers pour réduire les niveaux d'acide urique
EP3510162A4 (fr) Thérapie génique pour patients atteints d'anémie de fanconi
EP3397288A4 (fr) Méthodes pour diminuer l'expression de l'ataxine-2
EP3434291A4 (fr) Composition pour le traitement d'un disque intervertébral
EP3476478A4 (fr) Composition pour l'élimination de composés soufrés